Galen O Joe
Overview
Explore the profile of Galen O Joe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jorgensen J, Joe G, Jimenez-Silva R, Ho P, Dunigan T, Mitchell S, et al.
Transplant Cell Ther
. 2025 Mar;
PMID: 40054697
Background: Deficits in motor performance and functional abilities represent a severe complication for individuals with steroid refractory chronic graft versus host disease (cGVHD) and is associated with decreased survival and...
2.
Zhao A, Pirsl F, Steinberg S, Holtzman N, Schulz E, Mina A, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1377-1383.
PMID: 37684526
Patients with chronic graft-versus-host disease (cGVHD) are at heightened risk for components of metabolic syndrome (MetS), yet the prevalence and impact of MetS in the cGVHD patient population remain unknown....
3.
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
Beshensky D, Pirsl F, Holtzman N, Steinberg S, Mays J, Cowen E, et al.
Bone Marrow Transplant
. 2023 Jul;
58(10):1112-1120.
PMID: 37474729
Kidney complications have been studied in allogeneic hematopoietic stem cell transplant patients but not specifically among chronic graft-versus-host disease (cGVHD) patients. Participants (n = 365) enrolled in the cross-sectional cGVHD...
4.
Shieh V, Zampieri C, Stout P, Joe G, Kokkinis A, Fischbeck K, et al.
J Rehabil Med Clin Commun
. 2022 Sep;
5:2513.
PMID: 36072267
Objective: Spinal and bulbar muscular atrophy is characterized by slow-progressive muscle weakness, decreased functional performance and falls. Research into the use of exercise in spinal and bulbar muscular atrophy has...
5.
Shrader J, Sansare A, Shieh V, Woolstenhulme J, Rekant J, Jimenez-Silva R, et al.
Rehabil Res Pract
. 2021 Nov;
2021:2540324.
PMID: 34725572
Introduction: Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder that leads to progressive weakness of bulbar and extremity muscles. Dynamic balance during functional tasks has not been reported...
6.
Schaar D, Pirsl F, Holtzman N, Steinberg S, Nashed J, Ruben C, et al.
Transplant Cell Ther
. 2021 Aug;
27(11):937.e1-937.e7.
PMID: 34380090
Subsequent cancer (SC) is a significant cause of morbidity and mortality in long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) and treatment-related immunosuppression have been...
7.
Ruben C, Pirsl F, Steinberg S, Holtzman N, Parsons-Wandell L, Baruffaldi J, et al.
Bone Marrow Transplant
. 2021 Feb;
56(7):1584-1592.
PMID: 33526918
Malignancy relapse remains a major barrier to treatment success in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) markedly reduces hematologic malignancy relapse risk, but relapses...
8.
Moles-Poveda P, Comis L, Joe G, Mitchell S, Pichard D, Rosenstein R, et al.
Arch Phys Med Rehabil
. 2020 Dec;
102(4):776-788.
PMID: 33347890
Graft-versus-host disease (GVHD) is a multisystemic disorder that affects 30%-80% of patients who undergo allogeneic hematopoietic stem cell transplantation 10%-15% of GVHD patients develop sclerotic features affecting the skin or...
9.
Curtis L, Ostojic A, Venzon D, Holtzman N, Pirsl F, Kuzmina Z, et al.
Blood
. 2020 Sep;
137(7):896-907.
PMID: 32976576
Steroid-refractory chronic graft-versus-host disease (cGVHD) is a therapeutic challenge. Sclerotic skin manifestations are especially difficult to treat. We conducted a randomized phase 2 clinical trial (#NCT01688466) to determine the safety,...
10.
Rosenthal E, Ho P, Joe G, Mitchell S, Booher S, Pavletic S, et al.
Support Care Cancer
. 2019 Dec;
28(8):3679-3689.
PMID: 31811481
Purpose: To explore improvement in motor ability, function, health-related quality of life (HRQOL), and symptom severity in patients with sclerotic chronic graft-versus-host disease (ScGVHD) in response to treatment as well...